the recombinant dna technology in addition to subunit type vaccine allows to construct living vaccines which represent a dna-containing attenuated virus with build-in natural or synthetic gene of the capsid or chimeric protein with antigenic determinants of another viral species .
C0887892
subunit
C0042210
vaccines